1-4 of 4
Michele Baccarani, MD,PhD
Close
Sort by
Journal Articles

Survival and Prognosis in Patients with First-Line Imatinib Treatment Under Particular Consideration of Death Due to Chronic Myeloid Leukemia

Markus Pfirrmann, PhD, Susanne Saussele, MD PhD, Michele Baccarani, MD PhD, Joelle Guilhot, PhD, Francisco Cervantes, MD PhD, Gert J Ossenkoppele, MDPhD, Doris Lindoerfer, Verena S Hoffmann, Dr., Fausto Castagnetti, MD PhD, Rüdiger Hehlmann, MD, Bengt Simonsson, MD PhD
Journal: Blood
Blood (2014) 124 (21): 153.
https://doi.org/10.1182/blood.V124.21.153.153
Published: 2014
Journal Articles

Phase II Study of Proteasome Inhibitor Bortezomib (Velcade®) in Patients with Relapsed/Refractory T-Cell Lymphoma: Preliminary Results.

Pier Luigi Zinzani, MD, PhD, Monica Tani, MD, Gerardo Musuraca, MD, Vittorio Stefoni, MD, Enrica Marchi, MD, Mariapaola Fina, MD, Michele Baccarani, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2462.
https://doi.org/10.1182/blood.V108.11.2462.2462
Published: 2006
Journal Articles

A Phase II Trial of CHOP Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) for Previously Untreated Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients.

Pier Luigi Zinzani, MD, PhD, Monica Tani, MD, Stefano Fanti, MD, Vittorio Stefoni, MD, Gerardo Musuraca, MD, Paolo Castellucci, MD, Enrica Marchi, MD, Mariapaola Fina, MD, Michele Baccarani, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2431.
https://doi.org/10.1182/blood.V108.11.2431.2431
Published: 2006
Journal Articles

A Phase II Trial of FM (Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) for Previously Untreated Indolent Non-Follicular Lymphoma Patients.

Pier Luigi Zinzani, MD, PhD, Monica Tani, MD, Stefano Fanti, MD, Gerardo Musuraca, MD, Alessio Perrotti, MD, Umberto Vitolo, MD, Mariapaola Fina, MD, Barbara Botto, MD, Enrica Marchi, MD, Giulia Benevolo, MD, Vittorio Stefoni, MD, Michele Baccarani, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2478.
https://doi.org/10.1182/blood.V108.11.2478.2478
Published: 2006